Outcomes of lung transplantation for scleroderma versus other indications: Insigts from a single center
Our findings suggest that lung transplantation might be an important therapeutic option for patients with scleroderma, showing outcomes similar to those of patients with different underlying conditions.
Authors
- Ernest G. Chan (ORCID: https://orcid.org/0000-0001-9849-6371)
- Masashi Furukawa (ORCID: https://orcid.org/0000-0001-8102-9072)
- Chadi A. Hage (ORCID: https://orcid.org/0000-0002-0582-4362)
- Pablo G. Sánchez (ORCID: https://orcid.org/0000-0003-3607-0345)
- John P. Ryan (ORCID: https://orcid.org/0000-0003-4466-4418)
Institutions
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100266
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00